Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth (Q46187716)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth |
scientific article |
Statements
1 reference
Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemoth (English)
1 reference
Donald S Kaufman
1 reference
Kathryn A Winter
1 reference
William U Shipley
1 reference
Niall M Heney
1 reference
H James Wallace
1 reference
Leonard M Toonkel
1 reference
Anthony L Zietman
1 reference
Simon Tanguay
1 reference
Howard M Sandler
1 reference
18 December 2008
1 reference
1 reference
73
1 reference
4
1 reference
833-837
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference